Retina-Vitreous
2024 , Vol 33 , Num 4
Potential combination of vector delivered-endogenous anti- VEGF and recombinant tissue plasminogen activator: novel therapy for diabetic retinopathy
1Udayana University, Medical Program, Faculty of Medicine, Bali, Indonezya2Udayana University, Department of Ophthalmology, Faculty of Medicine, Bali, Indonezya DOI : 10.37845/ret.vit.2024.33.48 Keywords :